01 1Catalent Micron Technologies, Inc.
02 1Galenova Inc
03 4Isomedix Operations Inc
04 1Isomedix Operations, Inc
05 2Josun International Limited
06 1Medisca Inc.
07 3Pharmacia and Upjohn Company LLC
08 1Professional Compounding Centers of America dba PCCA
09 1Shandong Qilu King-phar Pharmaceutical Co., Ltd.
10 1Sichuan Long March Pharmaceutical Co. Ltd.
11 1Spectrum Laboratory Products, Inc.
12 5Yichang Sanxia Pharmaceutical Co., Ltd.
01 3NEOMYCIN SULFATE
02 15Neomycin Sulfate
03 4neomycin sulfate
01 1Canada
02 9China
03 11U.S.A
04 1United Kingdom
NDC Package Code : 51551-0307
Start Marketing Date : 2005-07-07
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 51551-0303
Start Marketing Date : 2017-02-04
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 38779-0348
Start Marketing Date : 2021-01-19
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 51927-1167
Start Marketing Date : 2002-07-19
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 0009-5238
Start Marketing Date : 2014-07-03
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 0009-5238
Start Marketing Date : 2014-07-03
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 0009-5238
Start Marketing Date : 2014-07-03
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 51671-0010
Start Marketing Date : 2010-12-17
End Marketing Date : 2027-06-08
Dosage Form (Strength) : POWDER (50kg/50kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 49452-4830
Start Marketing Date : 1986-01-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 55718-145
Start Marketing Date : 1995-10-30
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : DRUG FOR FURTHER PROCESSING
A Neomycin Sulfate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Neomycin Sulfate, including repackagers and relabelers. The FDA regulates Neomycin Sulfate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Neomycin Sulfate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Neomycin Sulfate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Neomycin Sulfate supplier is an individual or a company that provides Neomycin Sulfate active pharmaceutical ingredient (API) or Neomycin Sulfate finished formulations upon request. The Neomycin Sulfate suppliers may include Neomycin Sulfate API manufacturers, exporters, distributors and traders.
click here to find a list of Neomycin Sulfate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Neomycin Sulfate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Neomycin Sulfate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Neomycin Sulfate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Neomycin Sulfate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Neomycin Sulfate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Neomycin Sulfate suppliers with NDC on PharmaCompass.
We have 11 companies offering Neomycin Sulfate
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
